Previous 10 | Next 10 |
Highlights Full Year 2022 Revenue guidance in the range of $7,770 - $8,050 million, representing growth of 43 – 46% over Full Year 2021 Revenue guidance. Full Year 2022 adjusted earnings per share guidance in the range of $11.55 - $11.95, representing growth of 21 &...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 40 th Annual JP Morgan Healthcare Conference on Wednesday, January 12, 2022 at 07.30am ET. ...
Avantor is a fascinating way to play the broader science industry due to its vast portfolio of offerings. Recent performance by Avantor has been appealing, with revenue and cash flows rising while losses turn to profits. AVTR stock is pricey but relative to the growth the company ...
ICON continues to be recognised by peers, employees, and organisations around the globe ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisa...
The report looks to the future of ESG for the new ICON while highlighting advancements made in 2020 ICON plc (NASDAQ:ICLR) announced today the release of its 2020 Environmental, Social and Governance (ESG) Report. With the completion of ICON’s acquisition of P...
New partnerships increase geographical footprint, supporting more access to patients and strengthening therapeutic capability ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation services to pharmaceutical, biotechnology, medical device, a...
ICON Public Limited Company (ICLR) Q3 2021 Earnings Conference Call November 04, 2021 09:00 AM ET Company Participants Kate Haven - IR Steve Cutler - CEO Brendan Brennan - CFO Conference Call Participants Patrick Donnelly - Citi John Kreger - William Blair Elizabeth Anderson - Evercore Tycho ...
Image source: The Motley Fool. Icon PLC (NASDAQ: ICLR) Q3 2021 Earnings Call Nov 5, 2021 , 2:00 p.m. ET Operator Continue reading For further details see: Icon PLC (ICLR) Q3 2021 Earnings Call Transcript
Thermo Fisher Scientific has announced that it will acquire PPD for $47.50 per share. After having covered many biotechs for SA, I make sense of this acquisition from the perspective of pharmaceutical research, where PPD operates. In this case, by serving its pharma and biotech cu...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at: the 30th Annual Credit Suisse Healthcare Conference on Tuesday, November 9, 2021 at 8.50am ET; and ...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...